Legend Biotech Corporation (NASDAQ ... It puts CARVYKTI in the enviable position of providing patients with longer lives, ...

M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today announced that the Company has been awarded a $120,000 ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...

Layoffs sharply decreased between the first and second halves of the year, painting a fairly optimistic economic picture for the county, despite relatively flat venture capital funding levels last ...

When it comes to pharma and biotech giants, Risinger and Leerink concluded ... Under Khan, the FTC opposed Illumina’s (NASDAQ ...

Grail Inc. (GRAL) Grail is a biotechnology leader that has a troubled history with parent firm Illumina Inc. (ILMN), a top genomic sequencing company. Namely, Illumina built Grail internally, spun it ...

As of November 08, 2024, GRAIL, Inc. had a $449.6 million market capitalization, putting it in the 39th percentile of companies in the Biotechnology industry. GRAIL, Inc. does not have a meaningful ...

Exact Sciences' Q3 report led to a ~25% drop in share price, due to a slight guidance cut and narrow revenue miss. Learn more ...

Deal-making has slowed in recent years, largely due to high interest rates, soaring company valuations and a tight regulatory ...

As healthcare rapidly advances, AI-driven technologies present compelling investment opportunities. Hence, investors might ...

Volunteers aged between 50 and 77 are being sought to trial the diagnostic developed by California biotech Grail, which spun out of Illumina in 2016 and agreed to be reacquired by the lab ...

Grail IPO'd in June and despite the promise ... receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston ...